Comparative in vitro and in vivo efficacy of roxithromycin and erythromycin against a strain of methicillin-susceptible Staphylococcus epidermidis

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3050793 13 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Comparative in vitro and in vivo efficacy of roxithromycin and
erythromycin against a strain of methicillin-susceptible Staphylococcus
epidermidis
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
The in vitro and in vivo efficacy of roxithromycin was compared with
that of erythromycin, against a methicillin-susceptible strain of
Staphylococcus epidermidis. We performed standard in vitro testing (MIC,
MBC, and time-kill kinetics) for roxithromycin, erythromycin, and
rifampin. Both macrolides were bacteriostatic in vitro. There was no
significant difference in microbial survival between erythromycin and
roxithromycin groups in the time-kill kinetics (p = 0.3). For the in
vivo experiments, using the rabbit experimental endocarditis model,
roxithromycin was found to be inferior to erythromycin in decreasing the
microbial burden of the endocardial vegetations (p < 0.05). Rifampin was
highly effective, both in vitro and in vivo. In conclusion, the efficacy
of roxithromycin was poor and inferior to erythromycin against a strain
of methicillin-susceptible S. epidermidis. (C) 1998 Elsevier Science
Inc.
Έτος δημοσίευσης:
1998
Συγγραφείς:
Danias, PG
Chalevelakis, G
Mylonakis, EE
Argyropoulou, A and
Paniara, O
Saroglou, G
Raptis, SA
Περιοδικό:
Diagnostic Microbiology and Infectious Disease
Εκδότης:
EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
Τόμος:
32
Αριθμός / τεύχος:
1
Σελίδες:
51-54
Επίσημο URL (Εκδότης):
DOI:
10.1016/S0732-8893(98)00059-5
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.